Canaccord Genuity Maintains Arq (ARQ) Buy Recommendation

Canaccord Genuity maintained a Buy recommendation for Arq (NasdaqGM:ARQ) on November 7, 2025, with an average one-year price target of $10.91, implying a 183.48% upside from its latest closing price of $3.85. The company is projected to achieve $140MM in annual revenue, an 18.43% increase, and $0.16 non-GAAP EPS. Institutional sentiment remains bullish, with a 0.06 put/call ratio and a 2.75% increase in total institutional shares owned over the last quarter, despite a slight decrease in the number of reporting funds.

Analysis

Canaccord Genuity has reiterated a "Buy" recommendation for Arq (ARQ) as of November 7, 2025, with an average one-year price target of $10.91/share. This target implies a significant 183.48% upside from the recent closing price of $3.85, reflecting strong analyst conviction. The forecast range of $9.09 to $12.60 suggests a broad but generally positive outlook.
The positive outlook is underpinned by robust financial projections, with Arq anticipated to achieve $140MM in annual revenue, representing an 18.43% year-over-year increase. Non-GAAP EPS is projected at $0.16, indicating expected profitability. These figures suggest a healthy growth trajectory for the company.
Institutional investor sentiment appears largely bullish, evidenced by a low put/call ratio of 0.06 and a 2.75% increase in total institutional shares owned to 19,304K over the last quarter. While the number of reporting funds decreased by 2.46% (5 owners), the average portfolio weight dedicated to ARQ increased by 14.67% to 0.20%, indicating increased conviction among existing holders. Noteworthy, Gratia Capital and IWM increased their allocations significantly, while AIGH Capital Management reduced its position.

Key Decisions for Investors

• Investors should consider the significant 183.48% implied upside from Canaccord Genuity's $10.91 price target and the "Buy" recommendation as a strong bullish signal.
• Monitor Arq's actual revenue and non-GAAP EPS performance against the projected $140MM and $0.16, as these fundamental growth indicators are crucial for validating the analyst's outlook.
• Assess the nuanced institutional sentiment, noting the overall increase in shares owned and portfolio weight, alongside the divergent positioning of major holders, to understand conviction levels.